HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Mintel Forecasts Rise In Multifunctionals; Pureology Rides The Wave

This article was originally published in The Rose Sheet

Executive Summary

More multifunctional products will be entering the market in 2014, building on the success of BB and CC creams, Mintel predicts; Pureology is on trend with a new “multitasking hair beautifier.” More news in brief.

You may also be interested in...



From Sulfate-Free To Anti-Shampoo: Natural Movement In Hair Care

Trend for “free of” products in hair care is growing, as consumers demand gentle formulas created without ingredients that dry out hair and scalp, says global ingredient distributor Univar Inc. At extreme end of trend, some consumers are nixing shampoo altogether.

Insiders’ 2014 Forecast: Anti-Aging Hair Care To Drive Innovation

Hair-care formulas that address thinning and aging hair are in high demand, say personal-care ingredient distributors and custom manufacturers in separate interviews. New anti-aging and skin-brightening ingredients, as well as multifunctional products, also are trending, they note.

Future Use Of Titanium Dioxide In Spray And Powder Cosmetics Hinges On SCCS Review

As of 5 February, the Scientific Committee on Consumer Safety is evaluating use of titanium dioxide – now officially classified as a Category 2 carcinogen in the EU – in cosmetic products that can expose consumers by way of inhalation. Without a favorable SCCS opinion, the ingredient’s use in those contexts will be banned under Article 15 of the Cosmetics Regulation.

UsernamePublicRestriction

Register

RS018879

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel